Related references
Note: Only part of the references are listed.How I treat with maintenance therapy after allogeneic HCT
Zachariah DeFilipp et al.
BLOOD (2023)
Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend when and for whom in 2021?
Nico Gagelmann et al.
HAEMATOLOGICA (2021)
Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults
Yasuyuki Arai et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation
J. Kanda et al.
LEUKEMIA (2017)
Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults
Yasuyuki Arai et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies
Juliet N. Barker et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
A Novel Reduced-Toxicity Myeloablative Conditioning Regimen Using Full-Dose Busulfan, Fludarabine, and Melphalan for Single Cord Blood Transplantation Provides Durable Engraftment and Remission in Nonremission Myeloid Malignancies
Hisashi Yamamoto et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study
Y. Arai et al.
BONE MARROW TRANSPLANTATION (2016)
Nonmyeloablative allogeneic hematopoietic cell transplantation
Rainer Storb et al.
HAEMATOLOGICA (2016)
Nonmyeloablative allogeneic hematopoietic cell transplantation
Rainer Storb et al.
HAEMATOLOGICA (2016)
Effect of Granulocyte Colony-Stimulating Factor-Combined Conditioning in Cord Blood Transplantation for Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia: A Retrospective Study in Japan
Takaaki Konuma et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Single-unit cord blood transplant for acute lymphoblastic leukemia and lymphoma using an intensified conditioning regimen of total body irradiation, high-dose cytarabine and cyclophosphamide
Takaaki Konuma et al.
LEUKEMIA & LYMPHOMA (2015)
Single-Unit Cord Blood Transplantation after Granulocyte Colony-Stimulating Factor-Combined Myeloablative Conditioning for Myeloid Malignancies Not in Remission
Takaaki Konuma et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Granulocyte colony-stimulating factor combined regimen in cord blood transplantation for acute myeloid leukemia: a nationwide retrospective analysis in Japan
Takaaki Konuma et al.
HAEMATOLOGICA (2014)
Clinical Factors Predicting the Response of Acute Graft-versus-Host Disease to Corticosteroid Therapy: An Analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation
Makoto Murata et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia
Takehiko Mori et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS
S. M. Luger et al.
BONE MARROW TRANSPLANTATION (2012)
Defining the Intensity of Conditioning Regimens: Working Definitions
Andrea Bacigalupo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research
Sergio Giralt et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases
Naoyuki Ucbida et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia
Akio Shigematsu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation
Y. Inamoto et al.
BONE MARROW TRANSPLANTATION (2007)
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)
M Aoudjhane et al.
LEUKEMIA (2005)
Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor
Y Kanda et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)